Taiwan FDA registration 01f4e89404f9cb55fb6f20678336c9f7
"Kabi" red blood cell concentrate special white blood cell removal filter
TW: “卡比”紅血球濃縮液專用白血球去除過濾器
Taiwan·Risk Class 2·Fresenius Kabi AG; FRESENIUS HEMOCARE ITALIA S.R.L.·Registered May 06, 2019 – May 06, 2029ActiveRegistration details
- Analysis ID
- 01f4e89404f9cb55fb6f20678336c9f7
- Customs Code
- DHA05603242309
Company information
- Manufacturer Country
- Italy;;Germany
- Authorized Representative
- FRESENIUS KABI TAIWAN LIMITED
Product details
- Intended Use
- Remove white blood cells from the red blood cell concentrate.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- import
Dates and status
- Registration Date
- May 06, 2019
- Expiry Date
- May 06, 2029
About this record
Access comprehensive regulatory information for "Kabi" red blood cell concentrate special white blood cell removal filter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 01f4e89404f9cb55fb6f20678336c9f7 and manufactured by Fresenius Kabi AG; FRESENIUS HEMOCARE ITALIA S.R.L.. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices